한글목차

세계의 메타게놈 시퀀싱 시장 규모는 2023년 20억 달러에서 2028년까지 45억 달러에 달하며, CAGR로 17.5%의 성장이 예측됩니다. 시장의 성장을 촉진하는 주요 요인은 NGS 플랫폼에서의 지속적 기술 혁신 및 대규모 시퀀싱 프로젝트에 대한 정부와 민간 단체의 구상 및 자금 제공의 증가, 게놈 시퀀싱의 비용 하락입니다. 그러나 개발도상국에서의 자금과 예산 제약이 시장 성장을 어느 정도 억제할 전망입니다.

기술별로는 샷건 메타게놈 시퀀싱 부문이 이 기술이 제공하는 이점과 이 기술의 채택 확대에 의해 2022년에 시장에서 2번째로 큰 점유율을 차지했습니다.

용도별로는 Drug Discovery 부문이 2022년에 시장에서 최대 점유율을 차지했습니다. 이 시장 부문의 성장은 신약 연구 활동의 활발화가 주요 요인의 하나가 되고 있습니다.

북미는 시장에서 최대 점유율을 차지하고 있습니다. 북미 지역의 큰 점유율은 NGS 기반 메타게놈 기술의 채택에 대한 정부와 민간기관으로부터의 자금 제공, NGS 기반 메타게놈 연구 활동의 증가, 이 지역에서 주요 시장 기업의 강한 프레즌스 등의 요인에 의한 것입니다.

아시아태평양 시장은 예측 기간 중 가장 높은 CAGR로 성장할 것으로 예측되고 있습니다. 이것은 공적 기관뿐만 아니라 민간기관으로부터의 자금 제공이 증가하고 있는 것 등이 주요 요인입니다. 또한 이 지역에서는 NGS 기반 연구 프로젝트가 증가하고 있으며, 이것도 시장 성장을 지원할 전망입니다.

세계의 메타게놈 시퀀싱 시장에 대해 조사분석했으며, 주요 촉진요인과 억제요인, 경쟁 구도, 향후 동향 등의 정보를 제공하고 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

• 메타게놈 시퀀싱 시장의 개요
• 북미의 메타게놈 시퀀싱 시장 : 기술별, 국가별(2022년)
• 메타게놈 시퀀싱 시장 : 워크플로우별(2022년)
• 메타게놈 시퀀싱 시장 : 지역적 성장 기회

제5장 시장의 개요

• 서론
• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
  • 과제
• Porter's Five Forces 분석
• 밸류체인 분석
• 에코시스템 분석
• 특허 분석
• 공급망 분석
• 규제 분석
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동
• 가격 분석
• 무역 분석
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 주요 컨퍼런스와 이벤트(2023-2024년)
• 주요 이해관계자와 구입 기준

제6장 메타게놈 시퀀싱 시장 : 제품·서비스별

• 서론
• 시약·소모품
• 기구
• 시퀀싱 서비스
• 분석·데이터 해석 솔루션

제7장 메타게놈 시퀀싱 시장 : 기술별

• 서론
• 16S RRNA 시퀀싱
• 샷건 메타게놈 시퀀싱
• 전게놈 시퀀싱·de novo 어셈블리
• METATRANSCRIPTOMICS

제8장 메타게놈 시퀀싱 시장 : 워크플로우별

• 서론
• 샘플 처리·라이브러리 조정
• 시퀀싱
• 데이터 처리·분석

제9장 메타게놈 시퀀싱 시장 : 용도별

• 서론
• Drug Discovery
• 임상 진단
• 토양 마이크로바이옴 용도
• 산업 용도
• 생태학·환경적 용도
• 동물 의료 용도
• 기타 용도

제10장 메타게놈 시퀀싱 시장 : 지역별

• 서론
• 북미
  • 미국
  • 캐나다
  • 북미 : 불황의 영향
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 기타 유럽
  • 유럽 : 불황의 영향
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 기타 아시아태평양
  • 아시아태평양 : 불황의 영향
• 라틴아메리카
• 중동 및 아프리카

제11장 경쟁 구도

• 주요 기업의 전략
• 시장 점유율 분석
• 매출 분석
• 기업의 평가 쿼드런트(2022년)
• 경쟁 리더십 매핑(스타트업)(2022년)
• 상위 25사의 경쟁 벤치마킹
• 스타트업/중소기업의 경쟁 벤치마킹
• 경쟁 시나리오

제12장 기업 개요

• 주요 기업
  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • PERKINELMER, INC.
  • QIAGEN N.V.
  • OXFORD NANOPORE TECHNOLOGIES, PLC
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • BGI GROUP
  • PSOMAGEN, INC.
  • EUROFINS SCIENTIFIC
  • AZENTA, INC.(PART OF BROOKS AUTOMATION, INC.)
  • NOVOGENE CO., LTD.
  • ZYMO RESEARCH CORPORATION
  • TECAN TRADING AG
  • INTEGRAGEN SA
  • MICROSYNTH AG
  • DNASTAR, INC.
• 기타 기업
  • COSMOSID, INC.
  • MEDGENOME
  • TERRA BIOFORGE(FORMERLY VARIGEN BIOSCIENCES CORPORATION)
  • VERITAS GENETICS
  • BASECLEAR B.V.
  • METAGENOMI
  • COMPUTOMICS
  • NEW ENGLAND BIOLABS
  • INTACT GENOMICS, INC.

제13장 부록

영문목차

The global metagenomic sequencing market is projected to reach USD 4.5 billion by 2028 from USD 2.0 billion in 2023, at a CAGR of 17.5%. The key factors driving the growth of the metagenomic sequencing market are the continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing. However, funding and budget constraint in developing countries is expected to restrain market growth to a certain extent.

The metagenomic sequencing market has been segmented based on product & service, workflow, technology, application and region.

"By technology, the Shotgun Metagenomic Sequencing segment accounted for the second largest share of the metagenomic sequencing market"

Based on technology, the metagenomic sequencing market is categorized into 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing & de novo assembly, and metatranscriptomics. The Shotgun Metagenomic Sequencing segment accounted for the second largest share of the market in 2022, owing to the advantages that it offers and growing adoption of this technology.

"By applications, the drug discovery accounted for the largest share in the metagenomic sequencing market"

Based on applications, the metagenomic sequencing market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological & environmental applications, veterinary applications, and other applications. In 2022, the drug discovery segment accounted for a largest share of the metagenomic sequencing market. Growth in this market segment can be attributed to one of the major factors which is the increasing research activities for new drugs.

"North America: the largest share of the metagenomic sequencing market"

North America accounted for the largest share of the metagenomic sequencing market. The large share of the North America region can be attributed to major factors such as support from the government and private agencies terms of funding for adoption of NGS based metagenomic technologies, increase in the number of NGS based metagenomics activities as well as a strong presence of the key market players in the region.

"Asia Pacific: The fastest-growing region in the metagenomic sequencing market."

The Asia Pacific metagenomic sequencing market is projected to grow at the highest CAGR during the forecast period. This is attributed to one of the major factors including the increasing support from public as well as private agencies in terms of funding. Also, there has been an increase in the number of NGS-based research projects in the region which is also expected to support the market growth.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers - 45%, Directors- 30%, and Executives - 25%
• By Country: North America- 25%, Europe- 25%, Asia Pacific- 40%, Latin America- 5%, and Middle East & Africa- 5%

Prominent Players

• Illumina, Inc. (US)
• Thermo Fisher Scientific, Inc. (US)
• PerkinElmer, Inc. (US)
• QIAGEN N.V. (Netherlands)
• Oxford Nanopore Technologies, Plc. (UK)
• Pacific Biosciences of California, Inc. (US)
• BGI Group (China)
• Psomagen, Inc. (US)
• Eurofins Scientific, (Luxembourg)
• Azenta, Inc. (US)
• Novogene Co., Ltd. (China)
• Zymo Research Corporation (US)
• Tecan Trading AG (Switzerland)
• Integragen SA (France)
• Microsynth AG (Switzerland)
• DNAStar, Inc. (US)
• CosmosID, Inc. (US)
• MedGenome (US)
• Terra Bioforge (US)
• Veritas Genetics (US)
• BaseClear B.V. (Netherlands)
• Metagenomi (US)
• Computomics (Germany)
• New England Biolabs (US)
• Intact Genomics, Inc. (US)

Research Coverage:

This report provides a detailed picture of the metagenomic sequencing market. It aims at estimating the size and future growth potential of the market across different segments, such as the product & service, workflow, technology, application and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the metagenomic sequencing market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

The report provide insights on the following pointers"

• Analysis of key drivers (frequent innovations in technology of NGS platforms), opportunities (big data application in NGS), restraint (budget constraints in developing economies) and challenges (challenges associated with metagenomics NGS) influencing the growth of the metagenomic sequencing market.
• Product Development/ Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the metagenomic sequencing market.
• Market Development: Comprehensive information about lucrative markets- the report analyses the metagenomic sequencing market across varied regions.
• Market Diversification: Exhaustive information about new products and service, untapped geographies, recent developments, and investments in the metagenomic sequencing market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product and service offerings of leading players like Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), and Oxford Nanopore Technologies Plc. (UK) among others in the metagenomic sequencing market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • FIGURE 1 METAGENOMIC SEQUENCING MARKET SEGMENTATION
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY
• 1.5 LIMITATIONS
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES
  • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 2 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
  • FIGURE 3 METAGENOMIC SEQUENCING MARKET: BREAKDOWN OF PRIMARIES
    • 2.1.2.1 Key industry insights
• 2.2 MARKET ESTIMATION
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2022
  • FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE) - COLLECTIVE REVENUE OF ALL METAGENOMIC SEQUENCING PRODUCTS & SERVICES
  • FIGURE 6 METAGENOMIC SEQUENCING MARKET: MARKET SIZE ESTIMATION APPROACHES
• 2.3 GROWTH FORECAST
  • FIGURE 7 METAGENOMIC SEQUENCING MARKET: CAGR PROJECTIONS, 2023-2028
  • FIGURE 8 METAGENOMIC SEQUENCING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
• 2.5 RESEARCH LIMITATIONS
• 2.6 RISK ANALYSIS
• 2.7 RECESSION IMPACT
  • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

• FIGURE 10 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
• FIGURE 11 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2023 VS. 2028 (USD MILLION)
• FIGURE 12 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
• FIGURE 13 METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 14 GEOGRAPHICAL SNAPSHOT OF METAGENOMIC SEQUENCING MARKET

4 PREMIUM INSIGHTS

• 4.1 METAGENOMIC SEQUENCING MARKET OVERVIEW
  • FIGURE 15 TECHNOLOGICAL INNOVATIONS IN NGS PLATFORMS TO DRIVE GROWTH IN METAGENOMIC SEQUENCING MARKET
• 4.2 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY & COUNTRY (2022)
  • FIGURE 16 16S RRNA SEQUENCING TECHNOLOGY SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
• 4.3 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2022
  • FIGURE 17 SAMPLE PROCESSING & LIBRARY PREPARATION SEGMENT DOMINATED MARKET IN 2022
• 4.4 METAGENOMIC SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 19 METAGENOMIC SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Continuous technological innovations in NGS platforms
      • 5.2.1.1.1 Ion Torrent Genexus Dx Integrated Sequencer
      • 5.2.1.1.2 iSeq 100 System
      • 5.2.1.1.3 Ion GeneStudio S5
    • 5.2.1.2 Initiatives and funding from government & private bodies for large-scale sequencing projects
  • TABLE 2 GLOBAL SEQUENCING INITIATIVES
    • 5.2.1.3 Declining cost of genome sequencing
  • FIGURE 20 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001-2021
    • 5.2.1.4 Significant applications of metagenomics in various fields
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 End-user budget constraints in developing countries
    • 5.2.2.2 Stagnation in NGS product market in developed countries
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 NGS data analysis using big data
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Challenges associated with metagenomic NGS
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 METAGENOMIC SEQUENCING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT OF NEW ENTRANTS
  • 5.3.2 THREAT OF SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
• 5.4 VALUE CHAIN ANALYSIS
  • FIGURE 21 VALUE CHAIN ANALYSIS OF METAGENOMIC SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
  • FIGURE 22 VALUE CHAIN: METAGENOMIC SEQUENCING ANALYSIS WORKFLOW-MAXIMUM VALUE ADDED DURING SEQUENCING AND ANALYSIS PHASES
• 5.5 ECOSYSTEM ANALYSIS
  • FIGURE 23 ECOSYSTEM ANALYSIS: METAGENOMIC SEQUENCING MARKET
  • TABLE 4 SUPPLY CHAIN ECOSYSTEM
• 5.6 PATENT ANALYSIS
  • FIGURE 24 PATENT APPLICATIONS FOR METAGENOMIC SEQUENCING PRODUCTS, JANUARY 2012-JUNE 2023
  • TABLE 5 INDICATIVE LIST OF PATENTS IN METAGENOMIC SEQUENCING MARKET
• 5.7 SUPPLY CHAIN ANALYSIS
  • FIGURE 25 METAGENOMIC SEQUENCING MARKET: SUPPLY CHAIN ANALYSIS
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 NORTH AMERICA
    • 5.8.1.1 US
  • TABLE 6 US FDA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.8.1.2 Canada
  • 5.8.2 EUROPE
  • 5.8.3 ASIA PACIFIC
    • 5.8.3.1 China
  • TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
    • 5.8.3.2 Japan
    • 5.8.3.3 India
  • 5.8.4 LATIN AMERICA
  • 5.8.5 MIDDLE EAST
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS
  • TABLE 9 AVERAGE SELLING PRICE OF NGS SYSTEMS (2021)
• 5.10 TRADE ANALYSIS
  • 5.10.1 TRADE ANALYSIS FOR METAGENOMIC SEQUENCING MARKET
  • TABLE 10 IMPORT DATA FOR HS CODE 902780, BY COUNTRY, 2016-2020 (USD THOUSAND)
  • TABLE 11 EXPORT DATA FOR HS CODE 902780, BY COUNTRY, 2016-2020 (USD THOUSAND)
• 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.12 KEY CONFERENCES & EVENTS, 2023-2024
  • TABLE 12 METAGENOMIC SEQUENCING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF METAGENOMIC SEQUENCING PRODUCTS & SERVICES IN RESEARCH & ACADEMIC INSTITUTES
  • 5.13.2 BUYING CRITERIA FOR METAGENOMIC SEQUENCING MARKET
  • FIGURE 27 KEY BUYING CRITERIA FOR RESEARCH & ACADEMIC INSTITUTES

6 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE

• 6.1 INTRODUCTION
  • TABLE 13 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
• 6.2 REAGENTS & CONSUMABLES
  • 6.2.1 RISING ADOPTION OF METAGENOMIC SEQUENCING TO DRIVE ADOPTION OF REAGENTS & CONSUMABLES
  • TABLE 14 METAGENOMIC SEQUENCING MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 15 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 16 EUROPE: METAGENOMIC SEQUENCING MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 17 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.3 INSTRUMENTS
  • 6.3.1 LAUNCH OF ADVANCED NGS PLATFORMS TO SUPPORT GROWTH
  • TABLE 18 METAGENOMIC SEQUENCING MARKET FOR INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 19 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 20 EUROPE: METAGENOMIC SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 21 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.4 SEQUENCING SERVICES
  • 6.4.1 COST-EFFECTIVENESS OF OUTSOURCING NGS PROJECTS TO BOOST DEMAND FOR SERVICES
  • TABLE 22 METAGENOMIC SEQUENCING MARKET FOR SEQUENCING SERVICES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 23 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 24 EUROPE: METAGENOMIC SEQUENCING MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 25 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.5 ANALYSIS & DATA INTERPRETATION SOLUTIONS
  • 6.5.1 AVAILABILITY OF WIDE RANGE OF SOLUTIONS TO SUPPORT MARKET GROWTH
  • TABLE 26 METAGENOMIC SEQUENCING MARKET FOR ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 27 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 28 EUROPE: METAGENOMIC SEQUENCING MARKET FOR ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 29 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)

7 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY

• 7.1 INTRODUCTION
  • TABLE 30 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
• 7.2 16S RRNA SEQUENCING
  • 7.2.1 COST-EFFECTIVE TECHNIQUE FOR IDENTIFICATION OF BACTERIAL STRAINS TO DRIVE DEMAND
  • TABLE 31 16S RRNA SEQUENCING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 32 NORTH AMERICA: 16S RRNA SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 33 EUROPE: 16S RRNA SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: 16S RRNA SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.3 SHOTGUN METAGENOMIC SEQUENCING
  • 7.3.1 SHOTGUN METAGENOMIC SEQUENCING SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • TABLE 35 SHOTGUN METAGENOMIC SEQUENCING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 36 NORTH AMERICA: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 37 EUROPE: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 38 ASIA PACIFIC: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.4 WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY
  • 7.4.1 ABILITY OF WGS TO SEQUENCE COMPLETE METAGENOME OF ENVIRONMENTAL SAMPLES TO BOOST ADOPTION
  • TABLE 39 WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 40 NORTH AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 41 EUROPE: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.5 METATRANSCRIPTOMICS
  • 7.5.1 ABILITY OF METATRANSCRIPTOMICS TO STUDY ACTIVE FUNCTIONAL PROFILE OF MICROBIAL COMMUNITY TO FUEL GROWTH
  • TABLE 43 METATRANSCRIPTOMICS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 44 NORTH AMERICA: METATRANSCRIPTOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 45 EUROPE: METATRANSCRIPTOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: METATRANSCRIPTOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW

• 8.1 INTRODUCTION
  • TABLE 47 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
• 8.2 SAMPLE PROCESSING & LIBRARY PREPARATION
  • 8.2.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED SAMPLE PROCESSING AND LIBRARY PREPARATION ASSAY KITS TO DRIVE MARKET GROWTH
  • TABLE 48 METAGENOMIC SEQUENCING MARKET FOR SAMPLE PROCESSING & LIBRARY PREPARATION, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 49 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SAMPLE PROCESSING & LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 50 EUROPE: METAGENOMIC SEQUENCING MARKET FOR SAMPLE PROCESSING & LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR SAMPLE PROCESSING & LIBRARY PREPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.3 SEQUENCING
  • 8.3.1 GROWING PREFERENCE FOR SANGER SEQUENCING OVER NGS DUE TO ITS ADVANTAGES AND RAPIDITY TO BOOST MARKET
  • TABLE 52 METAGENOMIC SEQUENCING MARKET FOR SEQUENCING, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 54 EUROPE: METAGENOMIC SEQUENCING MARKET FOR SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET SEQUENCING, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.4 DATA PROCESSING & ANALYSIS
  • 8.4.1 TECHNOLOGICAL ADVANCEMENTS AND AVAILABILITY OF BROAD RANGE OF TOOLS TO SUPPORT MARKET GROWTH
  • TABLE 56 METAGENOMIC SEQUENCING MARKET FOR DATA PROCESSING & ANALYSIS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 57 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR DATA PROCESSING & ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 58 EUROPE: METAGENOMIC SEQUENCING MARKET FOR DATA PROCESSING & ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR DATA PROCESSING & ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)

9 METAGENOMIC SEQUENCING MARKET, BY APPLICATION

• 9.1 INTRODUCTION
  • TABLE 60 METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 9.2 DRUG DISCOVERY
  • 9.2.1 DRUG DISCOVERY APPLICATIONS TO ACCOUNT FOR LARGEST SHARE OF METAGENOMIC SEQUENCING MARKET DURING FORECAST PERIOD
  • TABLE 61 METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 62 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 63 EUROPE: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.3 CLINICAL DIAGNOSTICS
  • 9.3.1 ADVANTAGES OF METAGENOMIC NGS TO INCREASE APPLICATIONS IN DIAGNOSTICS
  • TABLE 65 METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 66 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 67 EUROPE: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.4 SOIL MICROBIOME APPLICATIONS
  • 9.4.1 NORTH AMERICA TO REGISTER HIGH DEMAND FOR METAGENOMIC SEQUENCING IN SOIL MICROBIOME APPLICATIONS
  • TABLE 69 METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 70 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 71 EUROPE: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.5 INDUSTRIAL APPLICATIONS
  • TABLE 73 METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 74 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 75 EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 76 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 77 METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 9.5.1 ENERGY
    • 9.5.1.1 Declining fossil fuel reserves and growing energy needs to drive demand
  • TABLE 78 METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 79 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 80 EUROPE: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.5.2 BIOREMEDIATION
    • 9.5.2.1 Need to monitor pollutant impact and contamination to provide opportunities for metagenomic sequencing in bioremediation
  • TABLE 82 METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 83 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 84 EUROPE: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.5.3 OTHER INDUSTRIAL APPLICATIONS
  • TABLE 86 METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 87 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 88 EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.6 ECOLOGICAL & ENVIRONMENTAL APPLICATIONS
  • 9.6.1 ABILITY OF METAGENOMIC SEQUENCING TO IDENTIFY INVASIVE AND ENDANGERED SPECIES TO BOOST ADOPTION
  • TABLE 90 METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 91 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 92 EUROPE: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 93 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.7 VETERINARY APPLICATIONS
  • 9.7.1 GROWING DEMAND FOR RAPID AND ACCURATE PATHOGEN DIAGNOSIS TO SUPPORT MARKET GROWTH
  • TABLE 94 METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 95 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 96 EUROPE: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.8 OTHER APPLICATIONS
  • TABLE 98 METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 99 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 100 EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

10 METAGENOMIC SEQUENCING MARKET, BY REGION

• 10.1 INTRODUCTION
  • TABLE 102 METAGENOMIC SEQUENCING MARKET, BY REGION, 2021-2028 (USD MILLION)
• 10.2 NORTH AMERICA
  • FIGURE 28 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET SNAPSHOT
  • TABLE 103 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 104 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 105 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 106 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 107 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 108 NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.2.1 US
    • 10.2.1.1 Well-established infrastructure and availability of funding to drive market growth
  • TABLE 109 US: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 110 US: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 111 US: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 112 US: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 113 US: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.2.2 CANADA
    • 10.2.2.1 Increasing government initiatives and workshops to support growth
  • TABLE 114 CANADA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 115 CANADA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 116 CANADA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 117 CANADA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 118 CANADA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.2.3 NORTH AMERICA: RECESSION IMPACT
• 10.3 EUROPE
  • TABLE 119 EUROPE: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 120 EUROPE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 121 EUROPE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 122 EUROPE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 123 EUROPE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 124 EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.3.1 GERMANY
    • 10.3.1.1 Growing investments in next-generation technologies to boost market
  • TABLE 125 GERMANY: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 126 GERMANY: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 127 GERMANY: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 128 GERMANY: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 129 GERMANY: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.3.2 FRANCE
    • 10.3.2.1 Government initiatives to support genomics research to drive growth
  • TABLE 130 FRANCE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 131 FRANCE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 132 FRANCE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 133 FRANCE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 134 FRANCE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.3.3 UK
    • 10.3.3.1 Favorable funding scenario for genomics research to support adoption of NGS
  • TABLE 135 UK: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 136 UK: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 137 UK: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 138 UK: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 139 UK: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.3.4 REST OF EUROPE
  • TABLE 140 REST OF EUROPE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 141 REST OF EUROPE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 142 REST OF EUROPE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 143 REST OF EUROPE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 144 REST OF EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.3.5 EUROPE: RECESSION IMPACT
• 10.4 ASIA PACIFIC
  • FIGURE 29 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET SNAPSHOT
  • TABLE 145 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.4.1 CHINA
    • 10.4.1.1 Increasing focus of key market players on strengthening their presence and offerings in China to drive market growth
  • TABLE 151 CHINA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 152 CHINA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 153 CHINA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 154 CHINA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 155 CHINA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.4.2 JAPAN
    • 10.4.2.1 Rising use of metagenomic sequencing for various applications to drive market growth in Japan
  • TABLE 156 JAPAN: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 157 JAPAN: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 158 JAPAN: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 159 JAPAN: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 160 JAPAN: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.4.3 INDIA
    • 10.4.3.1 Increasing collaborations and partnerships by various private and government bodies to drive market growth
  • TABLE 161 INDIA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 162 INDIA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 163 INDIA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 164 INDIA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 165 INDIA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.4.4 REST OF ASIA PACIFIC
  • TABLE 166 REST OF ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 167 REST OF ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 168 REST OF ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 169 REST OF ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 170 REST OF ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.4.5 ASIA PACIFIC: RECESSION IMPACT
• 10.5 LATIN AMERICA
  • 10.5.1 INTRODUCTION OF LOW-COST SEQUENCING TECHNOLOGIES TO DRIVE MARKET
  • TABLE 171 LATIN AMERICA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 172 LATIN AMERICA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 173 LATIN AMERICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 174 LATIN AMERICA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 175 LATIN AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.5.2 LATIN AMERICA: RECESSION IMPACT
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 RISING AWARENESS OF ADVANCED SEQUENCING TECHNOLOGIES TO DRIVE MARKET GROWTH IN COMING YEARS
  • TABLE 176 MIDDLE EAST & AFRICA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2021-2028 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 178 MIDDLE EAST & AFRICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
  • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

• 11.1 KEY PLAYER STRATEGIES
  • FIGURE 30 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN METAGENOMIC SEQUENCING MARKET
• 11.2 MARKET SHARE ANALYSIS
  • FIGURE 31 METAGENOMIC SEQUENCING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
  • TABLE 181 METAGENOMIC SEQUENCING MARKET: DEGREE OF COMPETITION
• 11.3 REVENUE ANALYSIS
  • FIGURE 32 REVENUE ANALYSIS FOR KEY COMPANIES (2020-2022)
• 11.4 COMPANY EVALUATION QUADRANT (2022)
  • 11.4.1 STARS
  • 11.4.2 PERVASIVE PLAYERS
  • 11.4.3 EMERGING LEADERS
  • 11.4.4 PARTICIPANTS
  • FIGURE 33 METAGENOMIC SEQUENCING MARKET: COMPANY EVALUATION MATRIX, 2022
• 11.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS) (2022)
  • 11.5.1 PROGRESSIVE COMPANIES
  • 11.5.2 STARTING BLOCKS
  • 11.5.3 DYNAMIC COMPANIES
  • 11.5.4 RESPONSIVE COMPANIES
  • FIGURE 34 COMPANY EVALUATION MATRIX FOR START-UPS, 2022
• 11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
  • 11.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
  • TABLE 182 COMPANY FOOTPRINT ANALYSIS, BY PRODUCT & SERVICE
  • 11.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
  • TABLE 183 COMPANY FOOTPRINT, BY REGION
• 11.7 COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • TABLE 184 METAGENOMIC SEQUENCING MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 185 METAGENOMIC SEQUENCING MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
• 11.8 COMPETITIVE SCENARIO
  • 11.8.1 PRODUCT LAUNCHES
  • TABLE 186 METAGENOMIC SEQUENCING MARKET: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2023
  • 11.8.2 DEALS
  • TABLE 187 METAGENOMIC SEQUENCING MARKET: DEALS, JANUARY 2020-JUNE 2023
  • 11.8.3 OTHER DEVELOPMENTS
  • TABLE 188 METAGENOMIC SEQUENCING MARKET: OTHER DEVELOPMENTS, JANUARY 2020-FEBRUARY 2023

12 COMPANY PROFILES

• 12.1 MAJOR PLAYERS

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**

• 12.1.1 ILLUMINA, INC.
• TABLE 189 ILLUMINA, INC.: BUSINESS OVERVIEW
• FIGURE 35 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
• TABLE 190 ILLUMINA, INC.: PRODUCT LAUNCHES & APPROVALS
• TABLE 191 ILLUMINA, INC.: DEALS
• TABLE 192 ILLUMINA, INC.: OTHER DEVELOPMENTS
• 12.1.2 THERMO FISHER SCIENTIFIC, INC.
• TABLE 193 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
• FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
• TABLE 194 THERMO FISHER SCIENTIFIC, INC.: PRODUCT LAUNCHES
• TABLE 195 THERMO FISHER SCIENTIFIC, INC.: DEALS
• 12.1.3 PERKINELMER, INC.
• TABLE 196 PERKINELMER, INC.: BUSINESS OVERVIEW
• FIGURE 37 PERKINELMER, INC.: COMPANY SNAPSHOT (2022)
• TABLE 197 PERKINELMER, INC.: PRODUCT LAUNCHES
• TABLE 198 PERKINELMER, INC.: DEALS
• 12.1.4 QIAGEN N.V.
• TABLE 199 QIAGEN N.V.: BUSINESS OVERVIEW
• FIGURE 38 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
• TABLE 200 QIAGEN N.V.: PRODUCT LAUNCHES
• TABLE 201 QIAGEN N.V.: DEALS
• TABLE 202 QIAGEN N.V.: OTHER DEVELOPMENTS
• 12.1.5 OXFORD NANOPORE TECHNOLOGIES, PLC
• TABLE 203 OXFORD NANOPORE TECHNOLOGIES, PLC: BUSINESS OVERVIEW
• FIGURE 39 OXFORD NANOPORE TECHNOLOGIES, PLC: COMPANY SNAPSHOT (2022)
• TABLE 204 OXFORD NANOPORE TECHNOLOGIES, PLC: PRODUCT LAUNCHES
• TABLE 205 OXFORD NANOPORE TECHNOLOGIES, PLC: DEALS
• 12.1.6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
• TABLE 206 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: BUSINESS OVERVIEW
• FIGURE 40 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT (2022)
• TABLE 207 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: PRODUCT LAUNCHES
• TABLE 208 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: DEALS
• 12.1.7 BGI GROUP
• TABLE 209 BGI GROUP: BUSINESS OVERVIEW
• TABLE 210 BGI GROUP: PRODUCT LAUNCHES
• TABLE 211 BGI GROUP: DEALS
• 12.1.8 PSOMAGEN, INC.
• TABLE 212 PSOMAGEN, INC.: BUSINESS OVERVIEW
• TABLE 213 PSOMAGEN, INC.: DEALS
• 12.1.9 EUROFINS SCIENTIFIC
• TABLE 214 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
• FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
• 12.1.10 AZENTA, INC. (PART OF BROOKS AUTOMATION, INC.)
• TABLE 215 AZENTA, INC. (PART OF BROOKS AUTOMATION, INC.): BUSINESS OVERVIEW
• FIGURE 42 AZENTA, INC. (PART OF BROOKS AUTOMATION, INC.): COMPANY SNAPSHOT (2022)
• 12.1.11 NOVOGENE CO., LTD.
• TABLE 216 NOVOGENE CO., LTD.: BUSINESS OVERVIEW
• TABLE 217 NOVOGENE CO., LTD.: SERVICE LAUNCHES
• TABLE 218 NOVOGENE CO., LTD.: DEALS
• 12.1.12 ZYMO RESEARCH CORPORATION
• TABLE 219 ZYMO RESEARCH CORPORATION: BUSINESS OVERVIEW
• TABLE 220 ZYMO RESEARCH CORPORATION: SERVICE LAUNCHES
• TABLE 221 ZYMO RESEARCH CORPORATION: DEALS
• 12.1.13 TECAN TRADING AG
• TABLE 222 TECAN TRADING AG: BUSINESS OVERVIEW
• FIGURE 43 TECAN TRADING AG: COMPANY SNAPSHOT (2022)
• 12.1.14 INTEGRAGEN SA
• TABLE 223 INTEGRAGEN SA: BUSINESS OVERVIEW
• FIGURE 44 INTEGRAGEN SA: COMPANY SNAPSHOT (2022)
• TABLE 224 INTEGRAGEN SA: DEALS
• 12.1.15 MICROSYNTH AG
• TABLE 225 MICROSYNTH AG: BUSINESS OVERVIEW
• 12.1.16 DNASTAR, INC.
• TABLE 226 DNASTAR: BUSINESS OVERVIEW
• *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
• 12.2 OTHER COMPANIES
  • 12.2.1 COSMOSID, INC.
  • 12.2.2 MEDGENOME
  • 12.2.3 TERRA BIOFORGE (FORMERLY VARIGEN BIOSCIENCES CORPORATION)
  • 12.2.4 VERITAS GENETICS
  • 12.2.5 BASECLEAR B.V.
  • 12.2.6 METAGENOMI
  • 12.2.7 COMPUTOMICS
  • 12.2.8 NEW ENGLAND BIOLABS
  • 12.2.9 INTACT GENOMICS, INC.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS